111In-labeled panitumumab
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for 111In-labeled panitumumab, covering 2026-03-05 to 2026-03-05. Get the full timeline:
Most recent: Clinical Trial Update: Evaluating 111In Panitumumab for Nodal Staging in Head and Neck Cancer [Phase 1]